• TechCrunch
• CrunchBase
• More
  • TechCrunch UK
  • TechCrunch France
  • TechCrunch Japan

Cerulean Pharma

edit

Cerulean Pharma Inc. is a privately-held biopharmaceutical company focused on the development of novel nanotechnology-based therapeutics in the areas of oncology, cardiovascular, autoimmune and inflammatory diseases.

The Company has assembled a world-class management team, board of directors and scientific advisory board that collectively have a significant track record of business building, product development and scientific breakthroughs from companies and institutions such as Cubist, GlaxoSmithKline, Merck, Millennium Pharmaceuticals, Inc., Pfizer, Wyeth, the Massachusetts Institute of Technology, Harvard Medical School, MD Anderson, Fox Chase Cancer Center and the Arizona Health Center.

Milestones

edit

• 
  Cerulean Pharma received $15M in Series D funding. (12/15/11)
  Posted 12/15/11 at 6:42pm via finsmes.com
• 
  Cerulean Pharma received $24M in Series C funding. (11/15/10)
  Posted 11/15/10 at 6:12pm via finsmes.com
• 
  Cerulean Pharma received $1.5M in Unattributed funding. (10/14/10)
  Posted 10/19/10 at 8:02pm via masshightech.com
• 
  Cerulean Pharma received $2M in Unattributed funding. (12/1/06)
  Posted 4/29/10 at 12:28am
• 
  Cerulean Pharma received $12.1M in Series A funding. (5/23/07)
  Posted 3/13/10 at 5:12am via ceruleanrx.com
• 
  Cerulean Pharma received $8.1M in Series B funding. (1/3/08)
  Posted 12/19/09 at 2:37am via ceruleanrx.com
• 
  Cerulean Pharma received $10M in Series B funding. (7/28/09)
  Posted 7/28/09 at 2:28pm via fiercebiotech.com
• 
  Cerulean Pharma — has closed a $24 million Series C financing led by Lilly Ventures, and named Steve Hall, a venture partner at Lilly Ventures, to the company’s board. (11/15/10)
  Posted 11/16/10 at 4:28am via masshightech.com

Videos

Screenshots

edit

Above: Cerulean
Uploaded: 12/19/09

Sources

1. Cap Funding Report [edit]
2. Tempo Pharmaceuticals Closes $12.1 Million in Series A Funding (ceruleanrx.com) [edit]
3. Tempo Pharmaceuticals Closes $8 Million in Series B Funding (ceruleanrx.com) [edit]
4. Cerulean pockets $10M as it catapults into the clinic (fiercebiotech.com) [edit]
5. Cerulean Pharma raises $1.5M financing (masshightech.com) [edit]
6. Cerulean Pharma Closes $24M Series C Financing (finsmes.com) [edit]
7. Cerulean Pharma Closes $15m Series D Financing (finsmes.com) [edit]
8. Cerulean Pharma pins down $24M in Series C funding (masshightech.com) [edit]